Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 99 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Grigoriadis, Nikolaos  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Parissis, D., Sintila S-A., Fotiadis P., Ioannidis P., & Grigoriadis N. (2020).  Acute Pain in the Neck: Don’t Miss the Crown!. The Neurohospitalist. 10(4), 318 - 319.
Parissis, D., Sintila S-A., Fotiadis P., Ioannidis P., & Grigoriadis N. (2020).  Acute Pain in the Neck: Don't Miss the Crown!. Neurohospitalist. 10(4), 318-319.
Lourbopoulos, A., Grigoriadis N., Lagoudaki R., Touloumi O., Polyzoidou E., Mavromatis I., et al. (2011).  Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis.. Brain Res. 1390, 126-41.
Bakirtzis, C., Grigoriadou E., Boziki M. Kleopatra, Kesidou E., Siafis S., Moysiadis T., et al. (2020).  The Administrative Prevalence of Multiple Sclerosis in Greece on the Basis of a Nationwide Prescription Database.. Front Neurol. 11, 1012.
Paspaltsis, I., Kesidou E., Touloumi O., Lagoudaki R., Boziki M., Samiotaki M., et al. (2020).  Application of antibody phage display to identify potential antigenic neural precursor cell proteins.. J Biol Res (Thessalon). 27, 14.
Hacohen-Kleiman, G., Yizhar-Barnea O., Touloumi O., Lagoudaki R., Avraham K. B., Grigoriadis N., et al. (2019).  Atypical Auditory Brainstem Response and Protein Expression Aberrations Related to ASD and Hearing Loss in the Adnp Haploinsufficient Mouse Brain.. Neurochem Res. 44(6), 1494-1507.
Sragovich, S., Malishkevich A., Piontkewitz Y., Giladi E., Touloumi O., Lagoudaki R., et al. (2019).  The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.. Transl Psychiatry. 9(1), 2.
C
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy.. Int J Cardiol. 229, 17-18.
Lourbopoulos, A., Mourouzis I., Karapanayiotides T., Nousiopoulou E., Chatzigeorgiou S., Mavridis T., et al. (2014).  Changes in thyroid hormone receptors after permanent cerebral ischemia in male rats.. J Mol Neurosci. 54(1), 78-91.
Zacharaki, D., Lagoudaki R., Touloumi O., Kotta K., Voultsiadou A., Poulatsidou K-N., et al. (2013).  Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells isolated from experimental autoimmune encephalomyelitis mice.. J Mol Neurosci. 51(2), 282-97.
Andravizou, A., Siokas V., Artemiadis A., Bakirtzis C., Aloizou A-M., Grigoriadis N., et al. (2020).  Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg?. Neurol Res. 42(7), 575-586.
Ifantopoulou, P., Artemiadis A. K., Bakirtzis C., Zekiou K., Papadopoulos T-S., Diakogiannis I., et al. (2019).  Cognitive and brain reserve in multiple sclerosis--A cross-sectional study.. Mult Scler Relat Disord. 35, 128-134.
Bakirtzis, C., Nikolaidis I., Boziki M-K., Artemiadis A., Andravizou A., Messinis L., et al. (2020).  Cognitive Fatigability is Independent of Subjective Cognitive Fatigue and Mood in Multiple Sclerosis. Cognitive and Behavioral Neurology. 33(2), 113 - 121.
Bakirtzis, C., Nikolaidis I., Boziki M-K., Artemiadis A., Andravizou A., Messinis L., et al. (2020).  Cognitive Fatigability is Independent of Subjective Cognitive Fatigue and Mood in Multiple Sclerosis.. Cogn Behav Neurol. 33(2), 113-121.
Tsivgoulis, G., Palaiodimou L., Katsanos A. H., Voumvourakis K., Hadjigeorgiou G. M., Heliopoulos I., et al. (2019).  Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis".. CNS Drugs. 33(3), 293-295.
Tsivgoulis, G., Katsanos A. H., Voumvourakis K., Hadjigeorgiou G. M., Heliopoulos I., Karapanayiotides T., et al. (2018).  Commentary on: Comparing the efficacy of disease-modifying therapies in multiple sclerosis.. Mult Scler Relat Disord. 21, 117-119.
Vilou, I., Bakirtzis C., Artemiadis A., Ioannidis P., Papadimitriou M., Konstantinopoulou E., et al. (2020).  Computerized cognitive rehabilitation for treatment of cognitive impairment in multiple sclerosis: an explorative study.. J Integr Neurosci. 19(2), 341-347.
Karapanayiotides, T., Geka E., Prassopoulos P., Koutroulou I., Kollaras P., Kiourtzieva E., et al. (2020).  Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: a lurking catastrophe?. Brain.
Theotokis, P., Kleopa K. A., Touloumi O., Lagoudaki R., Lourbopoulos A., Nousiopoulou E., et al. (2015).  Connexin43 and connexin47 alterations after neural precursor cells transplantation in experimental autoimmune encephalomyelitis.. Glia. 63(10), 1772-83.
Grigoriadis, N., Linnebank M., Alexandri N., Muehl S., & Hofbauer G. F. L. (2016).  Considerations on long-term immuno-intervention in the treatment of multiple sclerosis: an expert opinion.. Expert Opin Pharmacother. 17(15), 2085-95.
Boziki, M. Kleopatra, Mentis A-F. A., Shumilina M., Makshakov G., Evdoshenko E., & Grigoriadis N. (2020).  COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination.. Brain Sci. 10(6), 
Lourbopoulos, A., Matsoukas M-T., Katsara M., Deraos G., Giannakopoulou A., Lagoudaki R., et al. (2018).  Cyclization of PLP peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis.. Bioorg Med Chem. 26(9), 2221-2228.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.